PRIMO Software Licensing
ID: FDA-75F40124Q00495Type: Combined Synopsis/Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFFOOD AND DRUG ADMINISTRATIONFDA OFFICE OF ACQ GRANT SVCSBeltsville, MD, 20705, USA

NAICS

Other Computer Related Services (541519)

PSC

IT AND TELECOM - BUSINESS APPLICATION SOFTWARE (PERPETUAL LICENSE SOFTWARE) (7A21)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)

Original Source

https://sam.gov/opp/acbe34abe644426dbb7d37c708034ae6/view
Timeline
    Description

    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking qualified small businesses to provide PRIMO Software Licensing and Maintenance Support Services. The procurement involves supplying 21 PRIMO software licenses for a base year, with two additional option years, to ensure the continuous operation of the FDA's CFSAN CAEMS system. This software is crucial for pharmacovigilance and regulatory compliance, enhancing the FDA's capabilities in monitoring food safety. Interested parties must submit their quotes by August 26, 2024, and are encouraged to contact Roosevelt Walker at roosevelt.walker@fda.hhs.gov for further details. The contract will be awarded as a firm-fixed-price purchase order, emphasizing compliance with federal acquisition regulations and accessibility standards.

    Point(s) of Contact
    Roosevelt Walker
    roosevelt.walker@fda.hhs.gov
    Files
    Title
    Posted
    FDA_75F40124Q00495_Amend 0001.pdf
    The document is an amendment to a Request for Quote (RFQ) for PRIMO Software Licensing and Maintenance Support Services issued by the FDA. The RFQ is aimed at obtaining 21 licenses for PRIMO pharmacovigilance software over a base year and two option years, ensuring continuous operation of the FDA's CFSAN CAEMS system. The submission deadline for quotes is August 26, 2024. Key requirements include delivery of software licenses within five business days post-award, a kickoff meeting, and subsequent provision of user account access and monthly usage reports. The contract will be firm-fixed-price, emphasizing the importance of compliance with technical specifications and accessibility standards. Additionally, the solicitation highlights the evaluation criteria based on technical capability and pricing, mandates electronic invoice submission through the U.S. Department of Treasury’s Invoice Processing Platform, and emphasizes protections for sensitive information. The RFQ reflects the FDA's commitment to utilizing small businesses for procurement, ensuring compliance with federal regulations throughout the process.
    FDA_75F40124Q00495.pdf
    The document outlines a Request for Quote (RFQ) for PRIMO Software Licensing and Maintenance Support Services issued by the FDA (Solicitation Number FDA-SOL-75F40124Q00495). Scheduled for response by August 26, 2024, it is designated as a total Small Business Set Aside, with a firm fixed price purchase order anticipated. The contractor is required to provide 21 PRIMO software licenses for one base year (September 29, 2024, to September 28, 2025) and two option years, ensuring continuous usage of the CFSAN CAEMS system. Key deliverables include a kickoff meeting, user account information, and monthly usage reports. The solicitation stipulates that contractors must be authorized resellers or service agents and provides specific instructions regarding pricing, invoicing through the Treasury's IPP system, and compliance with security requirements for sensitive information. Evaluation criteria will focus on technical capability and price, emphasizing adherence to federal acquisition regulations and accessibility standards. This RFQ serves to enhance the FDA's software capability while ensuring compliance with regulations and promoting small business participation.
    Lifecycle
    Title
    Type
    PRIMO Software Licensing
    Currently viewing
    Combined Synopsis/Solicitation
    Similar Opportunities
    NTELX Perpetual License, Software Maintenance & Support
    Active
    Health And Human Services, Department Of
    The U.S. Food and Drug Administration (FDA) is seeking small business sources to provide a perpetual license, maintenance, and support for NTELX software, specifically for the Office of Regulatory Affairs (ORA). This procurement aims to ensure continuous operational support for mission-critical applications used by ORA staff, which are vital for optimizing import inspections and public health compliance under the Bioterrorism Act of 2002. The NTELX software, including key modules such as PREDICT, FDanalyzer, FDfusion, FDmonitor, and FDauditor, processes approximately 50 million lines of import data annually, making it essential for risk assessment and compliance targeting. Interested small businesses must submit their capability statements by November 14, 2024, and can contact Robert Waite at robert.waite@fda.hhs.gov for further information.
    Contractor-Hosted Fully Integrated Records Facility (FIRF) IDIQ
    Active
    Health And Human Services, Department Of
    The U.S. Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is conducting market research for a Contractor-Hosted Fully Integrated Records Facility (FIRF) services under an Indefinite Delivery-Indefinite Quantity (IDIQ) contract. The objective is to identify potential small business sources capable of providing comprehensive services such as document processing, data entry, and record tracking, aimed at enhancing the management of records related to public health. This initiative is crucial for improving operational efficiency and ensuring compliance with federal regulations, ultimately supporting the FDA's mission to safeguard public health. Interested vendors must submit their responses, including a completed Vendor Feedback Form and comments on the draft Statement of Work, via email to Contract Specialist Noah Wills by 12:00 PM (Eastern) on November 19, 2024, with the anticipated contract period running from September 15, 2025, to September 14, 2030.
    Business Data Enrichment Services
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking information on Business Data Enrichment Services to support the establishment of an enterprise master data management program. The primary objective is to enhance the accuracy and completeness of business data across operational and analytical systems, which is crucial for regulatory compliance and public health initiatives. This Request for Information (RFI) is part of the FDA's efforts to gather insights from the marketplace regarding potential solutions and capabilities, particularly in light of legislative requirements such as the Drug Supply Chain and Security Act. Interested stakeholders must submit their responses by November 15, 2024, and can direct inquiries to Noah Padilla at Noah.Padilla@fda.hhs.gov or Peter Lee at peter.lee@fda.hhs.gov.
    FDA Headquarters Consolidation Initiative - Workplace Enhancement and Management Services
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Food and Drug Administration (FDA), intends to award an 8(a) sole source contract for Workplace Enhancement and Management Services as part of the FDA Headquarters Consolidation Initiative. The primary objective of this procurement is to enhance space efficiency at the FDA Headquarters in Silver Spring, Maryland, necessitating comprehensive space planning, project management for office renovations, and furniture coordination. This initiative is crucial for optimizing the operational environment to support the FDA's mission of promoting public health, with a total estimated contract value of $4,269,388.87 for a base year and two optional years, starting January 1, 2025. Interested parties may submit qualifications and capabilities by 10:00 AM ET on November 12, 2024, to Andrea Howard at andrea.howard1@fda.hhs.gov or Sandra Bellinger at sandra.bellinger@fda.hhs.gov.
    Notice of Intent to Limiting sources
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), intends to award a fixed-price contract for Preventative Maintenance and Qualification Services for an Agilent GC/MS and HPLC system. The procurement is limited to Agilent Technologies or its authorized service provider network due to the highly specialized nature of the required services, which include diagnostic tests and the replacement of parts compliant with original equipment manufacturer (OEM) specifications. These services are critical for ensuring the safe and effective operation of the FDA's instruments, as using non-authorized providers could invalidate warranties and pose safety risks. Interested parties capable of meeting these requirements may submit written capability statements by 3:00 p.m. EST on November 12, 2024, to Elena Tatarov at elena.tatarov@fda.hhs.gov.
    Preventive Maintenance and Repair service for the Cryo-Cooler components of a Bruker Biospec 47/40 magnetic resonance imaging (MRI) unit (base year only)
    Active
    Health And Human Services, Department Of
    The U.S. Food and Drug Administration (FDA) is seeking small business sources to provide Preventive Maintenance and Repair services for the Cryo-Cooler components of a Bruker Biospec 47/40 magnetic resonance imaging (MRI) unit located at the National Center for Toxicological Research (NCTR) in Jefferson, Arkansas. The required services will span a one-year period starting from November 30, 2024, following the expiration of the current service contract, and interested vendors must submit capability statements detailing their qualifications, including past performance and the ability to meet specific performance requirements such as on-site maintenance and the use of OEM parts. This opportunity is critical for ensuring the reliable operation and maintenance of the MRI equipment in compliance with OEM specifications. Interested parties must submit their responses via email by November 7, 2024, and can contact Suzanne Martella at suzanne.martella@fda.hhs.gov for further information.
    Preventive Maintenance and Repair Services for a Sciex Triple Quad 5500+ QTRAP HPLC/MS/MS system and Agilent 1260 HPLC system
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking qualified contractors to provide preventive maintenance and repair services for a Sciex Triple Quad 5500+ QTRAP HPLC/MS/MS system and an Agilent 1260 HPLC system. The procurement includes a base year and three optional years of service, requiring one planned maintenance visit annually, prompt on-site corrective maintenance, adherence to OEM specifications, and the provision of software updates and factory-certified replacement parts. These services are critical for maintaining the operational efficiency of analytical equipment used in research at the National Center for Toxicological Research, ensuring that ongoing studies are not delayed. Interested parties should contact Warren Dutter at warren.dutter@fda.hhs.gov or call 870-543-7577 for further details, and the contract will be awarded based on technical capability and experience, with a firm-fixed price structure.
    Simplifi 797 and Simplifi+Medstorage or Equal
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 16, is seeking quotes for the procurement of Simplifi 797 and Simplifi+ MedStorage or equivalent software to enhance compliance with U.S. Pharmacopeial Convention (USP) standards for sterile compounding. The required software must provide a web-based quality management system that automates compliance with USP 795, 797, and 800 standards, while also facilitating necessary training and documentation for pharmacy staff to adhere to storage protocols and quality assurance practices in medication management. This acquisition is critical for maintaining high standards in medication safety and quality control, with quotes due by November 5, 2024, and the contract spanning a base period of one year with four additional option periods. Interested vendors should submit detailed quotes electronically, including past performance references and pricing, to Caleb Parker at caleb.parker@va.gov or by phone at (713) 791-1414 ext. 149866.
    THERMO-FISHER SampleManager License Maint Renewal (25M-09)
    Active
    Dept Of Defense
    The Department of Defense, through the Portsmouth Naval Shipyard, is seeking proposals for the renewal of Thermo-Fisher SampleManager licenses, specifically set aside for small businesses. This procurement aims to secure a firm-fixed-price order for the maintenance of these licenses, which are critical for the Digital Program Office's laboratory information management systems at four Naval Shipyards. The contract period is from February 28, 2025, to February 27, 2026, with proposals due by November 8, 2024, at 0800 EST. Interested vendors must submit their proposals via the SAM.gov platform and ensure they are registered in the SAM database; for further inquiries, contact Sarah Thibodeau at sarah.d.thibodeau.civ@us.navy.mil or call 207-994-4897.
    FY25 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Food and Drug Administration (FDA), is soliciting proposals for the FY25 Broad Agency Announcement (BAA) aimed at advancing research and development in regulatory science. This initiative seeks to acquire innovative research proposals that enhance the FDA's mission to protect public health by modernizing the evaluation of FDA-regulated products and improving post-market surveillance. Eligible applicants, including private organizations and academic institutions, are encouraged to submit proposals that address critical knowledge gaps and align with FDA priorities, with a submission deadline for full proposals set for February 24, 2025. Interested parties can contact Ian Weiss at Ian.Weiss@fda.hhs.gov or by phone at 301-796-5728 for further information.